The nature of human hazards associated with excessive intake of amino acids

Journal of Nutrition

Volumn 134, Issue 6 SUPPL., 2004, Pages

  Garlick, Peter J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Adverse effects; Amino acid; Dietary; Excessive; High intake; Toxicity

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASCORBIC ACID; ASPARAGINE; ASPARTIC ACID; BRANCHED CHAIN AMINO ACID; CYSTEINE; FOOD ADDITIVE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE;

ABDOMINAL CRAMP; ANOREXIA; BACKACHE; BLINDNESS; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DISSOCIATIVE DISORDER; DIZZINESS; EOSINOPHILIA; EYE PAIN; FATIGUE; FOLIC ACID BLOOD LEVEL; HEADACHE; HEALTH HAZARD; HUMAN; INSOMNIA; LEUKOCYTOSIS; LIVER DYSFUNCTION; MEMORY DISORDER; MENTAL DISEASE; MYALGIA; NAUSEA; NEUROTOXICITY; NONHUMAN; OBESITY; ORAL REHYDRATION THERAPY; OVERNUTRITION; PHYSICAL PERFORMANCE; PROTEIN INTAKE; PSYCHOLOGICAL ASPECT; SIDE EFFECT; STOMACH DISEASE; TOXICITY; VISUAL IMPAIRMENT; VOMITING;

ANIMALIA;

EID: 2642522134     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.6.1633s     Document Type: Conference Paper

References (120)

1. Harper, A. E, Benevenga, N. J. & Wohlheuter, R. M. (1970) Effects of ingestion of disproportionate amounts of amino acids. Physiol. Rev. 50: 428-558.
2. Benevenga, N. J. & Steele, R. D. (1984) Adverse effects of excessive consumption of amino acids. Annu. Rev. Nutr. 4: 157-181.
3. Joint FAO/WHO Expert Committee on Food Additives (1988) Toxicological Evaluation of Certain Food Additives and Contaminants. WHO Food Additive Series no. 22. Cambridge University Press, New York, NY.
4. Anderson, S. A., and Raiten, D. J. (1992) Safety of Amino Acids Used as Dietary Supplements. Prepared for Food and Drug Administration by Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD.
5. Food and Nutrition Board/Institute of Medicine 2002 Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients): Preliminary Report. Institute of Medicine, National Academy Press, Washington, DC.
6. Da Costa Ribeiro, H., Jr. & Lifshitz, F. (1991) Alanine-based oral rehydration therapy for infants with acute diarrhea. J. Pediatr. 118: S86-S90.
7. Patra, F. C., Sack, D. A., Islam, A., Alam, A. N. & Mazumder, R. N. (1989) Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. Br. Med. J. 298: 1353-1356.
8. Genuth, S. M. & Castro, J. (1974) Effects of oral alanine on blood beta-hydroxybutyrate and plasma glucose, insulin, free fatty acids, and growth hormone in normal and diabetic subjects. Metabolism 23: 375-386.
9. Koeslag, J. H., Levinrad, L. I. & Klaff, L. J. (1985) Pancreatic polypeptide response to exercise: effect of alanine and glucose ingestion in carbohydrate-starved athletes. S. Afr. Med. J. 67: 884-887.
10. Koeslag, J. H., Levinrad, L. I., Lochner, J. D. & Sive, A. A. (1985) Post-exercise ketosis in post-prandial exercise: effect of glucose and alanine ingestion in humans. J. Physiol. 358: 395-403.
11. Genuth, S. M. (1973) Effects of oral alanine administration in fasting obese subjects. Metabolism 22: 927-937.
12. Rocha, D. M., Faloona, G. R. & Unger, R. H. (1972) Glucagon-stimulating activity of 20 amino acids in dogs. J. Clin. Invest. 51: 2346-2351.
13. Barbul, A. (1986) Arginine: biochemistry, physiology, and therapeutic implications. J. Parenter. Enteral. Nutr. 10: 227-238.
14. Park, K. G. M., (1993) The immunological and metabolic effects of L-arginine in human cancer. Proc. Nutr. Soc. 52: 387-401.
15. Yeatman, T. J., Risley, G. L. & Brunson, M. E. (1991) Depletion of dietary arginine inhibits the growth of a metastatic tumor. Arch. Surg. 126: 1376-1382.
16. Massara, F., Martelli, S., Ghigo, E., Camanni, F. & Molinatti, G. M. (1979) Arginine-induced hypophosphatemia and hyperkaliemia in man. Diabete Metab. 5: 297-300.
17. Park, K., Heys, S. D., Blessing, K., Kelly, P., McNurlan, M. A., Eremin, O. & Garlick, P. J. (1992) Stimulation of human breast cancers by dietary L-arginine. Clin. Sci. (Lond.) 82: 413-417.
18. Caso, G., Matar, S., McNurlan, M. A., McMillan, D. N., Eremin, O. & Garlick, P. J. (1996) Metabolic effects of arginine on malignant tissues. Clin. Nutr. 15: 89-90.
19. Schainker, B. & Olney, J. W. (1974) Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy. J. Neural. Transm. 35: 207-215.
20. Reynolds, W. A., Filer, L. J., Jr. & Pitkin, R. M. (1971) Monosodium glutamate: absence of hypothalamic lesions after ingestion by newborn primates. Science 172: 1342-1344.
21. Carlson, H. E., Miglietta, J. T., Roginsky, M. S. & Stegink, L. D. (1989) Stimulation of pituitary hormone secretion by neurotransmitter amino acids in humans. Metabolism 38: 1179-1182.
22. Ahlborg, B., Ekelund, L.-G. & Nilsson, C.-G. (1968) Effect of potassium-magnesium-aspartate on the capacity for prolonged exercise in man. Acta Physiol. Scand. 74: 238-245.
23. De Haan, A., van Doorn, J. E. & Westra, H. G. (1985) Effects of potassium + magnesium aspartate on muscle metabolism and force development during short intensive static exercise. Int. J. Sports Med. 6: 44-49.
24. Maughan, R. J. & Sadler, D.J.M. (1983) The effects of oral administration of salts of aspartic acid on the metabolic response to prolonged exhausting exercise in man. Int. J. Sports Med. 4: 119-123.
25. Sen Gupta, J, S. & Srivastava, K. K. (1973) Effect of potassium-magnesium aspartate on endurance work in man. Indian J. Exp. Biol. 11: 392-394.
26. Ashley, D. V. & Anderson, G. H. (1975) Correlation between the plasma tryptophan to neutral amino acid ratio and protein intake in the self-selecting weanling. J. Nutr. 105: 1412-1421.
27. Fernstrom, J. D., Larin, F. & Wurtman, R. J. (1973) Correlations between brain tryptophan and plasma neutral amino acid levels following food consumption in rats. Life Sci. 13: 517-524.
28. Kakizoe, T., Nishio, Y., Honma, Y., Niijima, T. & Sugimura, T. (1983) L-Isoleucine and L-leucine are promoters of bladder cancer in rats. In: Cellular Interactions by Environmental Tumor Promoters: Proc. of the 14th International Symp. of the Princess Takamatsu Cancer Research Fund, Tokyo (Fujiki, H., Hecker, E., Moore, R. E., Sigimura, T. & Weinstein, I. B., eds.). Japan Sci. Soc. Press 32: 373-380.
29. Rukaj, A. & Sérougne, C. (1983) Effect of excess dietary cysteine on the biodynamics of cholesterol in the rat. Biochim. Biophys. Acta 753: 1-5.
30. Sérougne, C. & Rukaj, A. (1983) Plasma and lipoprotein cholesterol in rats fed L-amino acid-supplemented diets. Ann. Nutr. Metab. 27: 386-395.
31. Sérougne, C., Férézou, J. & Rukaj, A. (1987) A new relationship between cholesterolemia and cholesterol synthesis determined in rats fed an excess of cysteine. Biochim. Biophys. Acta 921: 522-530.
32. Olney, J. W. (1994) Excitotoxins in foods. Neurotoxicology 15: 535-544.
33. Davis, J. M., Spaide, J. K. & Himwich, H. E. (1972) Effects of tranylcypromine and L-cysteine on plasma amino acids in controls and schizophrenic patients. Am. J. Clin. Nutr. 25: 302-310.
34. Federation of American Societies for Experimental Biology (1995) Analysis of Adverse Reactions to Monosodium Glutamate (MSG) (Raiten, D. J., Talbot, J. M., and Fisher, K. D., eds.). Report prepared for Center for Food Safety and Applied Nutrition, Food and Drug Administration. Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD.
35. Food Standards Australia New Zealand (2003) Monosodium Glutamate: A Safety Assessment [online]. Technical Report Series no.20. http://www.foodstandards.gov.au/ [accessed March 29, 2004].
36. Olney, J. W. (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721.
37. Olney, J. W. (1989) Glutamate, a neurotoxic transmitter. J. Child Neurol. 4: 218-226.
38. Goldsmith, P. C. (2000) Neuroglial responses to elevated glutamate in the medial basal hypothalamus of the infant mouse. J. Nutr. 130: 1032S-1038S.
39. Olney, J. W. (1969) Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J. Neuropathol. Exp. Neurol. 28: 455-474.
40. Hara, S., Shibuya, T. & Nakakawaji, K. (1962) Observations of pharmacological actions and toxicity of sodium glutamate, with comparisons between natural and synthetic products. J. Tokyo Med. Coll. 20: 69-100.
41. Daniel, R. G. & Waisman, H. A. (1968) The effects of excess amino acids on the growth of the young rat. Growth 32: 255-265.
42. Stellar, E. & McElroy, W. D. (1948) Does glutamic acid have any effect on learning? Science 108: 281-283.
43. Little, A. D. 1953 Report submitted to International Mineral and Chemical Corp. dated 13 January 1953; submitted to WHO in 1970.
44. Ebert, A. G. (1979) The dietary administration of L-monosodium glutamate, DL-monosodium glutamate, and L-glutamic acid to rats. Toxicol. Lett. 3: 71-78.
45. Ebert, A. G, (1979) The dietary administration of monosodium glutamate or glutamic acid to C-57 black mice for 2 years. Toxicol. Lett. 3: 65-70.
46. Levey, S., Harroun, J. E. & Smyth, C. J. (1949) Serum glutamic acid levels and the occurrence of nausea and vomiting after the intravenous administration of amino acid mixtures. J. Lab. Clin. Med. 34: 1238-1248.
47. Zimmerman, F. T. & Burgmeister, B. B. (1959) A controlled experiment of glutamic acid therapy; first report summarizing thirteen years of study. Arch. Neurol. Psychiatry 81: 639-648.
48. Himwich, W. A., Petersen, I. M. & Graves, J. P. (1954) Ingested sodium glutamate and plasma levels of glutamic acid. J. Appl. Physiol. 1: 196-199.
49. Schaumburg, H. H., Byck, R., Gerstl, R. & Mashman, J. H. (1969) Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science 163: 826-828.
50. Kenney, R. A. & Tidball, C. S. (1972) Human susceptibility to oral monosodium L-glutamate. Am. J. Clin. Nutr. 25: 140-146.
51. Reif-Lehrer, L. (1976) Possible significance of adverse reactions to glutamate in humans. Fed. Proc. 32: 2205-2211.
52. Tarasoff, L. & Kelly, M. F. (1993) Monosodium L-glutamate: a double-blind study and review. Food Chem. Toxicol. 31: 1019-1035.
53. Kenney, R. A. (1986) The Chinese restaurant syndrome: an anecdote revisited. Food Chem. Toxicol. 24: 2205-2214.
54. Wilkin, J. K. (1986) Does monosodium glutamate cause flushing (or merely "glutamania")? J. Am. Acad. Dermatol. 15: 225-230.
55. Yang, W. H., Drouin, M. A., Herbert, H., Mao, Y. & Karsh, J. (1997) The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study. J. Allergy Clin. Immunol. 99: 757-762.
56. Geha, R. S., Beiser, A., Ren, C., Patterson, R., Greenberger, P., Grammer, L. C., Ditto, A. M., Harris, K. E., Shaughnessy, M. A., et al. (1998) Multicenter, double blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate. J. Allergy Clin. Immunol. 106: 973-980.
57. Stevenson, D. D. (2000) Monosodium glutamate and asthma. J. Nutr. 130: 1067S-1073S.
58. Ziegler, T. R., Benfell, K., Smith, R. J., Young, L. S., Brown, E., Ferrari-Baliviera, E., Lowe, D. K. & Wilmore, D. W. (1990) Safety and metabolic effects of L-glutamine administration in humans. J. Parenter. Enteral. Nutr. 14: 137S-146S.
59. Jiang, Z. M., Wang, L. J., Qi, Y., Liu, T. H., Qiu, M. R., Yang, N. F. & Wilmore, D. W. (1993) Comparison of parenteral nutrition supplemented with L-glutamine or glutamine dipeptides. J. Parenter. Enteral. Nutr. 17: 134-141.
60. Lacey, J. M., Crouch, J. B., Benfell, K., Ringer, S. A., Wilmore, C. K., Maguire, D. & Wilmore, D. W. (1996) The effects of glutamine-supplemented parenteral nutrition in premature infants. J. Parenter. Enteral. Nutr. 20: 74-90.
61. Wang, J.M.-L., Wong, K. C., Creel, D. J., Clark, W. M. & Shahangian, S. (1985) Effect of glycine on hemodynamic responses and visual evoked potentials in the dog. Anesth. Analg. 64: 1071-1077.
62. Vasudevan, S., Laconi, E., Abanobi, S. E., Rao, P. M., Rajalakshmi, S. & Sarma, D.S.R. (1987) Effect of glycine on the induction of orotic aciduria and urinary bladder tumorigenesis in the rat. Toxicol. Pathol. 15: 194-197.
63. Rose, W. C., Wixom, R. L., Lockhart, H. B. & Lambert, G. F. (1955) The amino acid requirements of man. XV. The valine requirement; summary and final observations. J. Biol. Chem. 217: 987-995.
64. Creel, D. J., Wang, J.M.-L. & Wong, K. C. (1987) Transient blindness associated with transurethral resection of the prostate. Arch. Ophthalmol. 105: 1537-1539.
65. 2++; toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801. Proc. Natl. Acad. Sci. USA 85: 6556-6560.
66. Mizutani, A. R., Parker, J., Katz, J. & Schmidt, J. (1990) Visual disturbances, serum glycine levels and transurethral resection of the prostate. J. Urol. 144: 697-699.
67. Wang, J.M-L., Creel, D. J. & Wong, K. C. (1989) Transurethral resection of the prostate, serum glycine levels, and ocular evoked potentials. Anesthesiology 70: 36-41.
68. Florea, I., Popa, M., Simionescu, L., Dinulescu, E. & Juvina, E. (1976) Clinical use of glycine intravenous load for diagnosis of growth hormone deficiency. Clin. Endocrinol. 5: 283-286.
69. Kerr, G. R., Wolf, R. C. & Waisman, H. A. (1965) Hyperlipemia in infant monkeys fed excess L-histidine. Proc. Soc. Exp. Biol. Med. 119: 561-562.
70. Solomon, J. K. & Geison, R. L. (1978) Effect of excess dietary L-histidine on plasma cholesterol levels in weanling rats. J. Nutr. 108: 936-943.
71. Harvey, P. W., Hunsaker, H. A. & Allen, K.G.D. (1981) Dietary L-histidine-induced hypercholesterolemia and hypocupremia in the rat. J. Nutr. 111: 639-647.
72. Geliebter, A. A., Hashim, S. A. & Van Itallie, T. B. (1981) Oral-L-histidine fails to reduce taste and smell acuity but induces anorexia and urinary zinc excretion. Am. J. Clin. Nutr. 34: 119-120.
73. Pinals, R. S., Harris, E. D., Burnett, J. B. & Gerber, D. A. (1977) Treatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trial. J. Rheumatol. 4: 414-419.
74. Kopple, J. D. & Swendseid, M. E. (1981) Effect of histidine intake on plasma and urine histidine levels, nitrogen balance and Nτ -methylhistidine excretion in normal and chronically uremic men. J. Nutr. 111: 931-942.
75. Giordano, C., De Santo, N. G., Rinaldi, S., Acone, D., Esposito, R. & Gallo, B. (1973) Histidine for treatment of uraemic anaemia. Br. Med. J. 4: 714-716.
76. Anderson, J. O., Combs, G. F., Groschke, A. C. & Briggs, G. M. (1951) Effect on chick growth of amino acid imbalances in diets containing low and adequate levels of niacin and pyridoxine. J. Nutr. 45: 345-360.
77. Haskell Laboratory for Toxicology and Industrial Medicine (1957) Lysine for dietary supplementation. Stine Laboratory, Grasselli Chemicals Department, Newark, DE.
78. Hevia, P., Kari, F. W., Ulman, E. A. & Visek, W. J. (1980) Serum and liver lipids in growing rats fed casein with L-lysine. J. Nutr. 110: 1224-1230.
79. Hevia, P., Ulman, E. A., Kari, F. W. & Visek, W. J. (1980) Serum lipids of rats fed excess L-lysine and different carbohydrates. J. Nutr. 110: 1231-1239.
80. Kato, T., Sano, M. & Mizutani, N. (1987) Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur. J. Pediatr. 146: 56-58.
81. Dubow, E., Maher, A., Gish, D. & Erk, V. (1958) Lysine tolerance in infants. J. Pediatr. 52: 30-37.
82. Snyderman, S. E., Norton, P. M., Fowler, D. I. & Holt, L. E., Jr. (1959) The essential amino acid requirements of infants: lysine. Am. J. Dis. Child. 97: 175-185.
83. Lasser, R. P., Schoenfeld, M. R. & Friedberg, C. K. (1960) L-Lysine monohydrochloride: a clinical study of its action as a chloruretic acidifying adjuvant to mercurial diuretics. N. Engl. J. Med. 263: 728-733.
84. Griffith, R. S., Walsh, D. E., Myrmel, K. H., Thompson, R. W. & Behforooz, A. (1987) Success of L-lysine therapy in frequently recurrent herpes simplex infection. Dermatologica 175: 183-190.
85. Steele, R. D., Barber, T. A., Lalich, J. & Benevenga, N. J. (1979) Effects of dietary-3-methylthiopropioriate on metabolism, growth and hematopoiesis in the rat. J. Nutr. 109: 1739-1751.
86. Benevenga, N. J., Yeh, M. H. & Lalich, J. J. (1976) Growth depression and tissue reaction to the consumption of excess dietary methionine and S-methyl L-cysteine. J. Nutr. 106: 1714-1720.
87. Edmonds, M. S. & Baker, D. H. (1987) Amino acid excesses for young pigs: effects of excess methionine, tryptophan, threonine or leucine. J. Anim. Sci. 64: 1664-1671.
88. Matsueda, S. & Niiyama, Y. (1982) The effects of excess amino acids on maintenance of pregnancy and fetal growth in rats. J. Nutr. Sci. Vitaminol. 28: 557-573.
89. Fau, D., Peret, J. & Hadjiisky, P. (1988) Effects of ingestion of high protein or excess methionine diets by rats for two years. J. Nutr. 118: 128-133.
90. Health and Welfare Canada (1990) Report of the Expert Advisory Committee on Amino Acids. Catalog no. H42-2/40-1990. Minister of Supply and Services, Ottawa, Ontario, Canada.
91. Floyd, J. C., Jr., Fajans, S. S., Conn, J.W.A., Knopf, R. F. & Rull, J. (1966) Stimulation of insulin secretion by amino acids. J. Clin. Invest. 45: 1487-1502.
92. Connor, H., Newton, D. J., Preston, F. E. & Woods, H. F. (1978) Oral methionine loading as a cause of acute serum folate deficiency: its relevance to parenteral nutrition. Postgrad. Med: J. 54: 318-320.
93. Antun, F. T., Burnett, G. B., Cooper, A. J., Daly, R. J., Smythies, J. R. & Zealley, A. K. (1971) The effects of L-methionine (without MAOJ) in schizophrenia. J. Psychiatr. Res. 8: 63-71.
94. Brattström, L. E., Hardebo, J. E. & Hultberg, B. J. (1984) Moderate homocysteinemia-a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 15: 1012-1016.
95. Prensky, A. L., Fishman, M. A. & Daftari, B. (1974) Recovery of rat brain from a brief hyperphenylalaninemic insult early in development. Brain Res. 73: 51-58.
96. Ryan-Harshman, M., Leiter, L. A. & Anderson, G. H. (1987) Phenylalanine and aspartame fail to alter feeding behavior, mood and arousal in men. Physiol. Behav. 39: 247-253.
97. Kampel, D., Kupferschmnidt, R. & Lubec, G. (1990) Toxicity of D-proline. In: Amino Acids: Chemistry, Biology and Medicine (Lubec, G. & Rosenthal, G. A., eds.), pp. 1164-1171. ESCOM, Leiden, The Netherlands.
98. Hayasaka, S., Saito, T., Nakajjima, H., Takahashi, O. & Mizuno, K. (1985) Clinical trials of vitamin B and proline supplementation for gyrate atrophy of the choroid and retina. Br. J. Ophthalmol. 69: 283-290.
99. Pepplinkhuizen, L., Bruinvels, J., Blom, W. & Moleman, P. (1980) Schizophrenia-like psychosis caused by a metabolic disorder. Lancet 1: 454-456.
100. Wilcox, J., Waziri, R., Sherman, A. & Mott, J. (1985) Metabolism of an ingested serine load in psychotic and nonpsychotic subjects. Biol. Psychiatry 20: 41-49.
101. Sauberlich, H. E. (1961) Studies on the toxicity and antagonism of amino acids for weanling rats. J. Nutr. 75: 61-72.
102. Sauberlich, H. E. (1956) Amino acid imbalance as related to methionine, isoleucine, threonine and tryptophan requirement in the rat or mouse. J. Nutr. 59: 353-370.
103. Growdon, J. H., Nader, T. M., Schoenfeld, J. & Wurtman, R. J. (1991) L-Threonine in the treatment of spasticity. Clin. Neuropharmacol. 14: 403-412.
104. Jarvenpää, A.-L., Rassin, D. K., Räihä, N.C.R. & Gaull, G. E. (1982) Milk protein quantity and quality in the term infant. II. Effects on acidic and neutral amino acids. Pediatrics 70: 221-230.
105. Funk, D. N., Worthington-Roberts, B. & Fantel, A. (1991) Impact of supplemental lysine or tryptophan on pregnancy course and outcome in rats. Nutr. Res. 11: 501-512.
106. Chung, T. K., Gelberg, H. B., Domer, J. L. & Baker, D. H. (1991) Safety of L-tryptophan for pigs. J. Anim. Sci. 69: 2955-2960.
107. Fregly, M. J., Rowland, N. E. & Sumners, C. (1989) Effect of chronic dietary treatment with L-tryptophan on spontaneous salt appetite of rats. Pharmacol. Biochem. Behav. 33: 401-406.
108. Wurtman, R. J., Hefti, F. & Melamed, E. (1981) Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 32: 315-335.
109. Schneider-Helmert, D. & Spinweber, C. L. (1986) Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology (Berl.) 89: 1-7.
110. Blauvelt, A. & Falanga, V. (1991) Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch. Dermatol. 127: 1159-1166.
111. Alam, S. Q., Rogers, Q. R. & Harper, A. E. (1966) Effect of tryosine and threonine on free amino acids in plasma, liver, muscle, and eye in the rat. J. Nutr. 89: 97-105.
112. Rich, L. F., Beard, M. E. & Burns, R. P. (1973) Excess dietary tyrosine and corneal lesions. Exp. Eye Res. 17: 87-97.
113. Wurtman, R. J. (1986) Strategies in the development of drugs that might be useful in cognitive disorders. Clin. Neuropharmacol. 9 (suppl. 3): S3-S7.
114. Arevalo, R., Castro, R., Palarea, M. D. & Rodriguez, M. (1987) Tyrosine administration to pregnant rats induces persistent behavioral modifications in the male offspring. Physiol. Behav. 39: 477-481.
115. Benedict, C. R., Anderson, G. H. & Sole, M. J. (1983) The influence of oral tyrosine and tryptophan feeding on plasma catecholamines in man. Am. J. Clin. Nutr. 38: 429-435.
116. Melamed, E., Glaeser, B., Growdon, J. H. & Wurtman, R. J. (1980) Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals. J. Neural Transm. 47: 299-306.
117. Rasmussen, D. D., Ishizuka, B., Quigley, M. E. & Yen, S.S.C. (1983) Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations. J. Clin. Endocrinol. Metab. 57: 760-763.
118. Banderet, L. E. & Lieberman, H. R. (1989) Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res. Bull. 22: 759-762.
119. Menkes, J. H., Welcher, D. W., Levi, H. S., Dallas, J. & Gretsky, N. E. (1972) Relationship of elevated blood tyrosine to the ultimate intellectual performance of premature infants. Pediatrics 49: 218-224.
120. Mamunes, P., Prince, P. E., Thornton, N. H., Hunt, P. A. & Hitchcock, E. S. (1976) Intellectual deficits after transient tyrosinemia in the term neonate. Pediatrics 57: 675-680.